Brevan Howard Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.95M Sell
8,341
-4,929
-37% -$2.48M 0.03% 323
2025
Q4
$6.2M Sell
13,270
-1,351
-9% -$627K 0.07% 190
2025
Q3
$6.23M Sell
14,621
-19,491
-57% -$7.55M 0.03% 204
2025
Q2
$13.1M Buy
+34,112
New +$12.3M 0.08% 135
2025
Q1
Sell
-6,793
Closed -$2.04M 1279
2024
Q4
$2.04M Sell
6,793
-5,416
-44% -$1.89M 0.01% 281
2024
Q3
$4.96M Buy
12,209
+2,099
+21% +$768K 0.03% 129
2024
Q2
$3.25M Buy
+10,110
New +$3.28M 0.03% 133
2024
Q1
Sell
-4,583
Closed -$1.24M 1133
2023
Q4
$1.24M Buy
+4,583
New +$1.13M 0.02% 192

Other funds holding HCA

Brevan Howard Capital Management's HCA Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its HCA Healthcare (HCA) stake by 37% in Q1 2026, selling an estimated $2.48M and leaving 8,341 shares worth $3.95M. The position accounts for 0.03% of the portfolio, ranked #323.

Brevan Howard Capital Management first reported a position in HCA in Q4 2023 and has held it in 8 quarters since. The position peaked at $13.1M in Q2 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Brevan Howard Capital Management held 8,341 shares of HCA Healthcare worth $3.95M as of Q1 2026.
  • Brevan Howard Capital Management sold 4,929 HCA Healthcare shares in Q1 2026, an estimated $2.48M.
  • HCA Healthcare made up 0.03% of Brevan Howard Capital Management's portfolio in Q1 2026, its #323 holding.
  • Brevan Howard Capital Management first reported a position in HCA Healthcare in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's HCA Healthcare position peaked at $13.1M in Q2 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.